In the News.. type 2 youth study, mini glucagon made easier, CGM via radio waves and more!
Diabetes Connections | Type 1 Diabetes
Release Date: 08/27/2021
Do We Need an At-Home A1C Test in the Age of CGM? Orange Biomed Says Yes
Diabetes Connections | Type 1 Diabetes
Making the case for a better at home A1C test. Orange Biomed is developing a compact, one-drop, at-home A1C testing device they say could make frequent A1C checks easier and more accessible than ever. They’re passionate about closing the gap for people who struggle to get to clinics regularly… and the research they share is compelling: four A1C tests a year can lead to a nearly 4% reduction in A1C levels. We’ll talk about why more frequent A1C monitoring matters—even in the era of continuous glucose monitoring—how their new device works, and what early clinical trial results look...
info_outline
She Turned Her Glucose Data Into Art. Could it Change How People See Diabetes?
Diabetes Connections | Type 1 Diabetes
What if your glucose graph became a tangible piece of art? Something you could pring out and put on your water bottle or the back of your laptop. I’ve seen this in person and it makes a big impact on people. This week I’m talking to Krista Shenaman about making this type of art, her journey with type 2 – and it’s been a journey, she took a “record breaking” 28 day walk after her diagnosis.. – why she thinks its helpful to look at data in a new way and more. Full disclosure: We recorded this interview way back in 2024! Technical issues and thought it was lost,...
info_outline
Dexcom’s 15-Day G7 Is Here: What’s Changing, What’s Next, and What You Need to Know
Diabetes Connections | Type 1 Diabetes
It’s been a big month for announcements from Dexcom! What does that mean for you? From the commercial launch of the 15 day sensor and a smart basal feature to the announced phase out of the G6 and more, I’m talking with Jessica Castle, vice president of Global Medical Affairs at Dexcom. We’re covering all of this news and she’s answering your questions. More about More about This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to Learn more about ...
info_outline
Inside Capitol Hill’s Fight for Diabetes Care: What These Advocates Need You to Know
Diabetes Connections | Type 1 Diabetes
We're looking at some major policy issues happening in Washington, and what you can really do to effect change. George Huntley is the CEO of . We’ve got a lot to cover: Medicare changes like competitive bidding that could dramatically limit access to CGMs and insulin pumps for seniors, the changing landscape around GLP 1 meds, and we talk about patient advocacy wins. I know some of you are cynical, but it can work. If you’ve ever thought your voice doesn’t matter, this conversation may change your mind. This podcast is not intended as medical advice. If you have those kinds of questions,...
info_outline
In the News... Libre Freestyle recall, Dexcom 15 day launch, Omnipod & Tandem updates, Medicare price adjustments and more!
Diabetes Connections | Type 1 Diabetes
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big FDA recall around Freestyle Libre (see more below to find out if you're affected), Dexcom launches their 15.5 day sensor, Omnipod announces enhancements, Tandem tests a fully closed loop (with high fat, high carb meals) and lots more! Find out Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures The best way to keep up with Stacey and the show is by...
info_outline
Preventing Type 1 Diabetes? Dr. Michael Haller on ATG Research (Plus, Afrezza for Kids)
Diabetes Connections | Type 1 Diabetes
We've got a research update on two of the topics you’ve told me you want to hear more about. First, research into Preventing type 1 – with a therapy that hasn’t been in the headlines.. and second, inhaled insulin for kids. We’re talking to , a peds endo who is at the forefront of these studies. We’ll be talking about something called ATG – which looks really good in very low dose trials – and about the latest studies around inhaled insulin for kids – which is in front of the FDA right now. This podcast is not intended as medical advice. If you have those kinds of questions,...
info_outline
Rethinking Type 1 Screening with Adam Schefter & Dr. Shara Bialo
Diabetes Connections | Type 1 Diabetes
With lots of family time coming up this week for many of us, it’s a great time to talk about screening for type 1. While this might seem to be a real downer of a Thanksgiving conversation, screening is now considered standard of care for people with a family history of T1D. My guests want to get the word out about that – and they’ve both walked the walk. Adam Schefter is ESPN Senior NFL Insider – his wife lives with type 1.. and Dr. Shara Bialo is a pediatric endo who lives with type 1. This podcast is not intended as medical advice. If you have those kinds of questions, please contact...
info_outline
Diabetes Sports Project: Competing at the highest levels with type 1 diabetes
Diabetes Connections | Type 1 Diabetes
The Diabetes Sprots project says it’s an organization built to inspire. What can we all learn about elite athletes with type 1 – the people running marathons and doing Iron Man competitions. And with the right support and education, how far can those athletes go? We’re talking about the Olympics and more with DSP founder Casey Boren and volunteer Lauren Adams, both of whom live with type 1 (and both of whom had done a ten mile run before we started taping). Learn more about This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health...
info_outline
In the News... It's World Diabetes Day! Top stories and headlines for Nov 14, 2025
Diabetes Connections | Type 1 Diabetes
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly...
info_outline
Inside Tandem’s Latest: catching up with VP of Product Management Marisa Fienup
Diabetes Connections | Type 1 Diabetes
We've got an update from Tandem Diabetes. We’re talking about Libre 3 plus integration, Lyumjev approval, Mobi tubeless, extended wear infusion sets and a lot more with VP of Product Management Marisa Fienup. She’s also answering your questions about tubing, alerts, and shares what’s next. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to Information and Learn more about Please visit our Sponsors & Partners - they help make the show...
info_outlineIt's "In the News..." the only LIVE diabetes newscast!
--
Top stories this week:
T2D screening guidelines to change
New Gvoke Kit approved
Gestational Diabetes cases up in younger women
Are magnets & radio waves coming to T1D care?
Update on #DiversityInDiabetes
--
Links and sources in the transcript
Check out Stacey's book: The World's Worst Diabetes Mom!
Join the Diabetes Connections Facebook Group!
Sign up for our newsletter here
-----
Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----
Get the App and listen to Diabetes Connections wherever you go!
Click here for iPhone Click here for Android
Episode Transcript below:
Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days. As always, I’m going to link up my sources in the Facebook comments – where we are live on Wednesday August 25th 2021 – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more if you want, whenever you want.
XX
In the News is brought to you by Real Good Foods! Find them in your local grocery store, Target or Costco. Real Food You Feel Good About Eating.
XX
Top story this week.. the number of young people with type 2 nearly doubled in the United States from 2001 to 2017. These researchers found significant increases in all types of diabetes among both sexes and across racial and ethnic groups.
Type 1 diabetes remains more common among white youth. The highest rates of type 2 diabetes were seen in youth who are Black or Native American.
It's interesting that these CDC and NIH researchers say they don’t know the cause of the huge increase in type 2. They talk about rising obesity, but wonder what’s behind that? They also wonder if it’s because of increased screenings, environment or something else.
https://www.reuters.com/business/healthcare-pharmaceuticals/diabetes-surges-among-american-youth-study-shows-2021-08-24/
XX
Big change recommended in screening for adults with type 2. The U.S. Preventive Services Task Force now recommends screening for people who are overweight starting at age 35… five years earlier than recommended right now. That would include 40% of the US adult population. This task force recommends screenings that insurance companies must completely cover, without out of pocket costs to the insured, under the Affordable Care Act.
XX
FDA approval for Gvoke Kit to treat severe hypoglycemia. Xeris pharmaceuticals already provides Gvoke glucagon as an autoinjector and a prefilled syringe.. this Kit is for patients who prefer to draw up their own doses of glucagon using a vial and syringe. You don’t have to mix anything, it’s still a ready-to-use liquid glucagon.
Could be helpful to those who prefer mini-glucagon doses – which are NOT FDA approved – but are sometimes used during illness. Note that’s my comment, Xeris and the FDA is not talking about mini glucagon dosing at all.
https://www.fiercepharma.com/drug-delivery/xeris-a-rival-to-lilly-and-novo-gets-fda-nod-for-glucagon-kit
XX
Growing numbers of pregnant women are developing gestational diabetes. Between 2011 and 2019, rates of gestational diabetes in the United States jumped 30%, according to a large nationwide study of first-time mothers. The cause? Not clear. Every age group saw an increase – from 15 to 44 – so it’s not just moms getting older, which is happening. These researchers want to look at non -traditional risk factors like stress. This was a huge study – 13 million moms in the US.
https://www.upi.com/Health_News/2021/08/18/diabetes-pregnancy/7401629306285/
XX
In the – no thank you – department – researchers say they’ve got an implanted pump you’d refill just by swallowing a capsule. The catch? First, they have to implant the pump – which is described as the size of flip phone - along the abdominal wall, interfaced with the small intestine.
That refill capsule is magnetic, so the implant draws the capsule toward it. It then punches the capsule with a retractable needle and pumps the insulin into its reservoir. The needle must also punch through a thin layer of intestinal tissue to reach the capsule.
These Italian developers testing it all out in pigs – they say it controlled blood glucose successfully… for several hours.
https://spectrum.ieee.org/implantable-medical-devices
XX
Another maybe it’ll work item… Israeli startup Hagar has something called G-Wave technology that measures blood sugar levels using noninvasive radio waves.
The prototype puts the tech into a ceramic bracelet. Uses Bluetooth to transmit readings to an a mobile app with display and alert functions.
A proof-of-concept study found the company's radio frequency technology was able to continuously measure glucose levels with at least 90% accuracy, compared to the estimated 70% rate for traditional continuous glucose monitors. They claim that’s because it measures glucose in real time. Hagar now plans to launch clinical trials to pursue FDA approval
XX
More to come, but first, I want to tell you about one of our great sponsors who helps make Diabetes Connections possible.
Real Good Foods. Where the mission is Be Real Good
They make nutritious foods— grain free, high in protein, never added sugar and from real ingredients— I was in Target this week and I saw the new Entrée bowls, I bought the Lemon Chicken and the Lasagna. The Lemon chicken was great! It uses hearts of palm pasta instead of regular noodles which I thought sounded odd but really tasted good. They keep adding to the menu line! You can buy online or find a store near you with their locator right on the website. I’ll put a link in the FB comments and as always at d-c dot com.
Back to the news…
XX
Big grant goes to Scripps Whittier Diabetes Institute to study the use of CGMs in hospitalized patients with type 2. This is a $3.1 million dollar grant from The National Institutes of Health. It’s to build on research going on now – during the COVID-19 pandemic.
CGM devices have been approved for outpatient use since 1999, but their use in the hospital setting remains limited to research efforts and the special conditions allowed during the pandemic.
XX
Congrats to Diversity in Diabetes for their newly minted 501c3 status.
The group was founded last summer and is dedicated to creating awareness and providing solutions to end health disparities and the lack of representation in the diabetes space. Their big event – People of Color Living with Diabetes Virtual Summit kicks off Sept 16 – more info and how to register in the show notes.
XX
Please join me wherever you get podcasts for our next episode -Tuesday – we’re talking to the folks from MannKind, makers of Afrezza inhalable insulin. You had a lot of questions for them.. looking forward to that episode! The episode out right now is with Kyle Banks – a Broadway performer diagnosed with type 1 while acting in the Lion King.
That’s In the News for this week.. if you like it, please share it! If you’re watching this replay on YouTube please subscribe, if you’re listening via the audio podcast please follow. Whatever it’s called – I appreciate you being here. Thanks for joining me!